Home › Neuroendocrine Tumors › Texas › Dallas
Neuroendocrine Tumors clinical trials in Dallas, TX
6 studies for Neuroendocrine Tumors are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- UT Southwestern Medical Center, Dallas
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
RecruitingObservational study
- Clinical Research Institute at Methodist Health System, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RecruitingPhase 4
- UT Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Dallas
Neuroendocrine Tumors trials in other cities
- Washington, DC11 studies
- St. Louis, MO9 studies
- Philadelphia, PA8 studies
- Houston, TX7 studies
- Columbus, OH7 studies
- Rochester, MN7 studies
- Portland, OR6 studies
- Cleveland, OH6 studies
- Mountain View, CA6 studies
- Boston, MA6 studies
- Los Angeles, CA6 studies
- Chicago, IL6 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer53 studies
- Metastatic Cancer44 studies
- Heart Failure42 studies
- Cancer (all types)40 studies
- Prostate Cancer39 studies
- Colorectal Cancer34 studies
- Obesity33 studies
- Ovarian Cancer31 studies
- Bladder Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.